跳至主要内容
临床试验/NCT05394324
NCT05394324已完成不适用

A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision Products

Johnson & Johnson Surgical Vision, Inc.13 个研究点 分布在 3 个国家目标入组 1,674 人开始时间: 2022年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,674
试验地点
13
主要终点
BCDVA

研究概览

简要总结

Retrospective collection of data from medical records, multicenter, post-market clinical follow-up study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients who have been implanted with and/or undergone ophthalmic surgery using targeted JJSV products
  • Status post ophthalmic surgery between 1 day and 24 months for Year
  • Subsequent years after Year 1 will be between 1 day and 18 months.

排除标准

  • Concurrent participation (during the retrospective follow-up period) in an interventional (drug, device, biologic, etc.) clinical trial
  • Use of surgical devices not in accordance with the product labeling or indications for use
  • Degenerative visual disorders (e.g., macular degeneration or other retinal disorders) that cause visual acuity losses to a level worse than 0.2 logMAR (0.63 decimal, 6/9.5 or 20/32 Snellen) during the retrospective data collection period
  • Use of systemic or ocular medications that may affect vision during the retrospective data collection period
  • Known ocular disease or pathology that, in the opinion of the investigator may confound study findings during the retrospective data collection period
  • Pregnancy, lactating, or other condition associated with hormonal fluctuation that could lead to refractive changes during the retrospective data collection period.

结局指标

主要结局

BCDVA

时间窗: up to 12 months post-operation

The proportion of eyes achieving 20/40 or better BCDVA.

Incidence of Adverse Events

时间窗: up to 12 months post-operation

incidence of adverse events that are specified in the ISO 11979-7 Safety and Performance Endpoints.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验